Calcium Hydroxylapatite (CaHA) injections Longueuil-sur-le-parc
Over time, skin loses volume, firmness, and elasticity due to a natural decline in collagen and elastin production. This can lead to facial wrinkles, sagging, and a loss of definition. Health Canada-approved injectable treatments can help restore lost volume and support the skin’s natural regenerative processes, contributing to improved structure and long-lasting results.
Unlike hyaluronic acid fillers, which primarily provide hydration and volume, this injectable treatment offers a dual-action approach. Its formula contains calcium hydroxylapatite (CaHA) microspheres suspended in a gel carrier. Upon injection, the gel provides immediate volume, smoothing deeper wrinkles and enhancing facial contours. Over time, as the gel is gradually absorbed, the CaHA microspheres help stimulate the body’s natural collagen production. This process reinforces the skin’s structure, improving firmness, elasticity, and overall skin quality.
Since collagen production declines with age, calcium hydroxylapatite (CaHA) injections offer an innovative option for individuals looking to restore lost volume while supporting skin structure. Unlike traditional dermal fillers, this type of treatment helps stimulate the skin’s natural regenerative processes. However, results may vary depending on factors such as age, skin condition, and overall health.
What to Expect During Your Session
Personalized Assessment
Proceed with Treatment
Follow Up
Treatment & Technology
At Dermapure Longueuil-sur-le-Parc, calcium Hydroxylapatite (CaHA) injections are offered as a non-surgical injectable treatment to support skin firmness and facial structure. Care is provided in a professional clinical setting with a focus on safety, guidance, and individualized support.
Calcium Hydroxylapatite (CaHA) injections in Longueuil are available at our Longueuil-sur-le-Parc clinic. Discover the treatments offered in Longueuil and schedule an appointment to explore your care options.
Contraindications
Calcium hydroxylapatite (CaHA) injections may not be suitable for individuals who are pregnant or breastfeeding; have a history of severe allergies or an allergic reaction to any of the product’s ingredients; have an active skin infection in the treatment area; or have a bleeding disorder or are taking blood thinners. A consultation with a qualified healthcare provider is required to determine whether this treatment is appropriate and to discuss potential risks and considerations.